109 related articles for article (PubMed ID: 22006260)
1. Improved transnasal transport and brain uptake of tizanidine HCl-loaded thiolated chitosan nanoparticles for alleviation of pain.
Patel D; Naik S; Misra A
J Pharm Sci; 2012 Feb; 101(2):690-706. PubMed ID: 22006260
[TBL] [Abstract][Full Text] [Related]
2. Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
Patel D; Naik S; Chuttani K; Mathur R; Mishra AK; Misra A
J Drug Target; 2013 Sep; 21(8):759-69. PubMed ID: 23879335
[TBL] [Abstract][Full Text] [Related]
3. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
4. Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model.
Md S; Khan RA; Mustafa G; Chuttani K; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2013 Feb; 48(3):393-405. PubMed ID: 23266466
[TBL] [Abstract][Full Text] [Related]
5. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
Chen CH; Lin YS; Wu SJ; Mi FL
Carbohydr Polym; 2018 Aug; 193():163-172. PubMed ID: 29773368
[TBL] [Abstract][Full Text] [Related]
6. Cell line-dependent cytotoxicity of poly(isobutylcyanoacrylate) nanoparticles coated with chitosan and thiolated chitosan: Insights from cultured human epithelial HeLa, Caco2/TC7 and HT-29/MTX cells.
Pradines B; Lievin-Le Moal V; Vauthier C; Ponchel G; Loiseau PM; Bouchemal K
Int J Pharm; 2015 Aug; 491(1-2):17-20. PubMed ID: 26051544
[TBL] [Abstract][Full Text] [Related]
7. Tailorable thiolated trimethyl chitosans for covalently stabilized nanoparticles.
Verheul RJ; van der Wal S; Hennink WE
Biomacromolecules; 2010 Aug; 11(8):1965-71. PubMed ID: 20578733
[TBL] [Abstract][Full Text] [Related]
8. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
Haque S; Md S; Fazil M; Kumar M; Sahni JK; Ali J; Baboota S
Carbohydr Polym; 2012 Jun; 89(1):72-9. PubMed ID: 24750606
[TBL] [Abstract][Full Text] [Related]
9. Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice.
Sunena ; Singh SK; Mishra DN
Curr Drug Deliv; 2019; 16(1):51-58. PubMed ID: 30289074
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
Javia A; Thakkar H
J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
[TBL] [Abstract][Full Text] [Related]
11. Optimised nanoformulation of bromocriptine for direct nose-to-brain delivery: biodistribution, pharmacokinetic and dopamine estimation by ultra-HPLC/mass spectrometry method.
Md S; Haque S; Fazil M; Kumar M; Baboota S; Sahni JK; Ali J
Expert Opin Drug Deliv; 2014 Jun; 11(6):827-42. PubMed ID: 24655115
[TBL] [Abstract][Full Text] [Related]
12. Comparative biophysical properties of tenofovir-loaded, thiolated and nonthiolated chitosan nanoparticles intended for HIV prevention.
Meng J; Zhang T; Agrahari V; Ezoulin MJ; Youan BB
Nanomedicine (Lond); 2014 Aug; 9(11):1595-612. PubMed ID: 24405490
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
14. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
15. Thiolated chitosan nanoparticles as an oral delivery system for Amikacin: in vitro and ex vivo evaluations.
Atyabi F; Talaie F; Dinarvand R
J Nanosci Nanotechnol; 2009 Aug; 9(8):4593-603. PubMed ID: 19928123
[TBL] [Abstract][Full Text] [Related]
16. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa.
Dünnhaupt S; Barthelmes J; Hombach J; Sakloetsakun D; Arkhipova V; Bernkop-Schnürch A
Int J Pharm; 2011 Apr; 408(1-2):191-9. PubMed ID: 21295123
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
[TBL] [Abstract][Full Text] [Related]
18. Development and Evaluation of Optimized Thiolated Chitosan Proniosomal Gel Containing Duloxetine for Intranasal Delivery.
Khatoon M; Sohail MF; Shahnaz G; Ur Rehman F; Fakhar-Ud-Din ; Ur Rehman A; Ullah N; Amin U; Khan GM; Shah KU
AAPS PharmSciTech; 2019 Aug; 20(7):288. PubMed ID: 31410741
[TBL] [Abstract][Full Text] [Related]
19. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
[TBL] [Abstract][Full Text] [Related]
20. Brain targeted nanoparticulate drug delivery system of rasagiline via intranasal route.
Mittal D; Md S; Hasan Q; Fazil M; Ali A; Baboota S; Ali J
Drug Deliv; 2016; 23(1):130-9. PubMed ID: 24786489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
